Literature DB >> 1623247

Immunology of multiple sclerosis.

T Olsson1.   

Abstract

Recent advances in the understanding of the immunology of multiple sclerosis (MS) are discussed. In the central nervous system (CNS) major histocompatibility complex (MHC) class I and II antigens, and lymphocyte adhesion molecules are expressed. Furthermore, there are cells present which produce important effector molecules such as interferon (IFN)-gamma and tumor necrosis factor (TNF). A role for myelin antigen-specific autoimmunity is supported, but not proven, by the presence of a marked quantitative increase of T and B cells with such specificities, enriched to the CNS. Several myelin antigens, as well as a multitude of peptide parts of these, are apparently recognized. It will be of interest to study the functional abilities of these cells and how they are regulated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623247

Source DB:  PubMed          Journal:  Curr Opin Neurol Neurosurg        ISSN: 0951-7383


  10 in total

Review 1.  Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis.

Authors:  Omar Khan; Rana Zabad; Christina Caon; Marina Zvartau-Hind; Alexandros Tselis; Robert Lisak
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis.

Authors:  Aaron Boster; Mary Pat Bartoszek; Colleen O'Connell; David Pitt; Michael Racke
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

Review 3.  Are current immunological concepts of multiple sclerosis reflected by the immunopathology of its lesions?

Authors:  H Lassmann; K Vass
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.

Authors:  S Inogés; J Merino; E Bandrés; P De Castro; M L Subirá; A Sánchez-Ibarrola
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

5.  High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood.

Authors:  M Yu; S Fredrikson; J Link; H Link
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

6.  Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration.

Authors:  Heather A Arnett; Ying Wang; Glenn K Matsushima; Kinuko Suzuki; Jenny P-Y Ting
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

7.  Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders.

Authors:  J Roddy; I Clark; B L Hazleman; D A Compston; N J Scolding
Journal:  J Neurol       Date:  1994-08       Impact factor: 4.849

Review 8.  Viral mouse models used to study multiple sclerosis: past and present.

Authors:  J E Libbey; R S Fujinami
Journal:  Arch Virol       Date:  2021-02-13       Impact factor: 2.685

9.  Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.

Authors:  Burcu Ayoglu; Anna Häggmark; Mohsen Khademi; Tomas Olsson; Mathias Uhlén; Jochen M Schwenk; Peter Nilsson
Journal:  Mol Cell Proteomics       Date:  2013-06-03       Impact factor: 5.911

10.  The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis.

Authors:  M Mustafa; C Vingsbo; T Olsson; A Ljungdahl; B Höjeberg; R Holmdahl
Journal:  Eur J Immunol       Date:  1993-12       Impact factor: 5.532

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.